Dissemination requested by: Vada Furlan - Student at University of California Irvine, Urology Department
Dissemination timeframe: March 2, 2026 - April 13, 2026
Who should take this survey?
Doctors, RN's, PA's, CNP's
Details:
This survey is designed to understand how clinicians with meaningful experience in women’s health actually prescribe and manage testosterone therapy for female patients in everyday practice. It explores who is being treated, how treatment decisions are made, how therapy is monitored, and when clinicians choose to continue or discontinue treatment. By examining real-world patterns, the survey seeks to identify where practice is consistent, where it varies, and where clinicians encounter uncertainty that may not be fully addressed by existing evidence.
The survey aligns with the mission of the Sexual Medicine Society of North America by contributing practice-based data to advance the scientific understanding and clinical management of sexual health concerns. SMSNA promotes evidence-informed, multidisciplinary approaches to sexual medicine across diverse patient populations. By examining prescribing behaviors, this study supports SMSNA’s goals of improving patient care and informing the development of more comprehensive and clinically relevant guidance.
To take the survey, click HERE.
The option to disseminate a survey is a benefit of SMSNA membership. If you are a member of SMSNA, below are the guidelines for initiating a request and the process by which a survey is vetted and approved. This process is meant to facilitate fair and objective handling of all requests. Please allow up to 2-weeks for consideration.
If you are a nonprofit or an industry representative and want to disseminate a survey, please contact the SMSNA Executive Office at
Process: Any survey proposed for dissemination to the SMSNA membership, including those surveys developed by Committees on behalf of the SMSNA, will requires the following:
Dissemination:
Cost:
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.